Imunon
IMNN
24 hedge funds and large institutions have $1.69M invested in Imunon in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
4% more funds holding
Funds holding: 23 → 24 (+1)
0.29% more ownership
Funds ownership: 0.7% → 0.99% (+0.29%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
37% less capital invested
Capital invested by funds: $2.66M → $1.69M (-$972K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $36K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
+$776K |
| 2 |
Two Sigma Advisers
New York
|
+$209K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$147K |
| 4 |
Renaissance Technologies
New York
|
+$72.2K |
| 5 |
Citigroup
New York
|
+$31.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$166K |
| 2 |
Two Sigma Investments
New York
|
-$43.9K |
| 3 |
BlackRock
New York
|
-$20.2K |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$17K |
| 5 |
Morgan Stanley
New York
|
-$1.1K |
IMNN Hedge Fund Activity: Q2 2022 in Review
24 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2022, worth a combined $1.69M — down 37% from $2.66M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IMNN positions and 4 closed out — a net gain of 1 holder — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Murchinson, opening a new position worth an estimated $776K. The largest seller was Citadel Advisors, exiting entirely with an estimated $166K sold.
- 24 institutional investors held Imunon (IMNN) as of Q2 2022, up from 23 in Q1 2022.
- Funds reported $1.69M of Imunon stock for Q2 2022, down 37% quarter-over-quarter.
- 5 funds opened new Imunon positions in Q2 2022 and 4 closed out, a net change of +1 holder.
- The largest Imunon buyer in Q2 2022 was Murchinson, an estimated $776K added.
- The largest Imunon seller in Q2 2022 was Citadel Advisors, an estimated $166K sold.
Based on aggregated 13F filings for Q2 2022.